Navigation Links
New FASEB analysis documents impact of budget cuts on biomedical research

Bethesda, MD The Federation of American Societies for Experimental Biology (FASEB) released a new analysis of National Institutes of Health (NIH) funding trends highlighting the devastating impact of sequestration on the nation's capacity to support critical research. The FASEB analysis follows a May 15th Senate Appropriations Committee hearing featuring NIH Director, Francis Collins, MD, PhD, who testified that the $1.6 billion cut the agency sustained in FY 2013 due to sequestration is "having a substantial impact on the scientific community."

According to data from the NIH Website compiled by FASEB:

  • In constant dollars (adjusted for inflation), the NIH budget in FY 2013 is at its lowest level since FY 2000.

  • NIH awards are expected to drop from the 9,032 made in FY 2012 to an estimated 8,283 in FY 2013 (an 8.3 percent decrease).

A bipartisan group of senators joined Appropriations Committee Chair Barbara Mikulski (D-MD), Labor, Health and Human Services Subcommittee Chair Tom Harkin (D-IA) and subcommittee ranking member Jerry Moran (R-KS) in pledging to work together to do everything possible to increase the NIH budget in FY 2014.

FASEB urges Congress to restore the cuts and sustain the federal investment in NIH with a FY 2014 appropriation of at least $32 billion.


Contact: Lawrence Green
Federation of American Societies for Experimental Biology

Page: 1

Related biology news :

1. FASEB 2013 Excellence in Science Award recipient announced
2. Undergraduate Student Summer Research Award recipients announced for the 2012 FASEB MARC summer research opportunity program
3. FASEB lauds Air India for transporting research animals
4. FASEB urges biomedical research community to speak out against sequestration
5. FASEB SRC announces conference: Gastrointestinal Tract XV: Epithelia, Microbes, Inflammation & Cancer
6. FASEB SRC announces conference registration open: The Biology of Calpains in Health and Disease
7. FASEB SRC announces: Mechanism and Regulation of Prokaryotic Transcription Conference
8. FASEB SRC announces conference: Renal Hemodynamics: Integrating with the Nephron & Beyond
9. FASEB SRC announces conference registration open for: Ciliate Molecular Biology
10. FASEB SRC announces conference registration open for: Mechanisms in Plant Development Conference
11. FASEB SRC announces conference registration open for: Hematologic Malignancies
Post Your Comments:
(Date:6/7/2016)... 7, 2016  Syngrafii Inc. and San Antonio ... that includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" ... collaboration will result in greater convenience for SACU ... while maintaining existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/1/2016)... NEW YORK , June 1, 2016 ... Biometric Technology in Election Administration and Criminal Identification to ... According to a recently released TechSci Research report, " ... Sector, By Region, Competition Forecast and Opportunities, 2011 - ... $ 24.8 billion by 2021, on account of growing ...
(Date:5/9/2016)... 2016 Elevay is currently known ... freedom for high net worth professionals seeking travel for ... connected world, there is still no substitute for a ... sealing your deal with a firm handshake. This is ... advantage of citizenship via investment programs like those offered ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... NC (PRWEB) , ... June 27, 2016 , ... ... mission to bring innovative medical technologies, services and solutions to the healthcare market. ... and implementation of various distribution, manufacturing, sales and marketing strategies that are necessary ...
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
Breaking Biology Technology: